ARRIVENT BIOPHARMA INC (AVBP)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Zhengbin Bing Yao, Ph.D Chief Executive Officer and President | 2025 | $596,667 | $0 | $0 | $8,405,486 | $358,000 | $14,000 | $9,374,153 |
| 2024 | $558,183 | $0 | $0 | $1,596,043 | $238,623 | $13,800 | $2,406,649 | |
| 2023 | $536,475 | $0 | $0 | $394,693 | $241,414 | $13,200 | $1,185,782 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Stuart Lutzker, M.D., Ph.D President, Research and Development | 2025 | $515,779 | $0 | $0 | $2,654,364 | $247,574 | $14,000 | $3,431,717 |
| 2024 | $495,941 | $0 | $0 | $297,457 | $179,035 | $13,534 | $985,967 | |
| 2023 | $476,867 | $0 | $0 | $119,326 | $219,359 | $13,200 | $828,752 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Winston Kung, MBA Chief Financial Officer and Treasurer | 2025 | $492,417 | $0 | $0 | $2,654,364 | $246,287 | $14,000 | $3,407,068 |
| 2024 | $469,602 | $0 | $0 | $1,190,331 | $158,840 | $13,800 | $1,832,573 | |
| 2023 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |